After I tweeted about my recent post about Immunium, another Twitter user made me aware of iCancer. Why? – Because the clinical trial financed through the iCancer fundraising campaign used the Ad5PTDf35-adenovirus vector which Immunicum includes as one of their treatment platforms under development.
I thought I kick off the year with an article about Immunicum, a Swedish company I stumbled across a week or so ago. As an immunologist by training I have a soft spot for companies looking to exploit the versatility and strength of our own immune system. Immunicum does just that. In their own words, they aim to create “the […]
Exsel Group are certainly doing something right if the company’s recent accolades are anything to go by. Having started in 2014 with just three members of staff; today the IT and communications company can boast a turnover of almost £3million, 48 members of staff and three offices across Scotland. With this in mind, it’s little surprise that the business has just […]
The first time I met Beverley was when we were both helping at a conference that was organised by postgraduates for prospective research students at the University of Aberdeen in 2012 – the PhD Journey Conference, which was masterminded by Catherine MacDonald, a fellow PhD student. Thereafter, we kept loosely in touch via LinkedIn and finally met up one fine afternoon […]